BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress
BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress GlobeNewswire December 01, 2025 SUNNYVALE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces it will participate at the CSI Focus Devices […]